CN104324205A - Traditional Chinese medicine composition for treating heart diseases - Google Patents
Traditional Chinese medicine composition for treating heart diseases Download PDFInfo
- Publication number
- CN104324205A CN104324205A CN201410717143.4A CN201410717143A CN104324205A CN 104324205 A CN104324205 A CN 104324205A CN 201410717143 A CN201410717143 A CN 201410717143A CN 104324205 A CN104324205 A CN 104324205A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- heart diseases
- treating heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention relates to a traditional Chinese medicine composition for treating heart diseases, relating to the technical field of heart disease medicines and aiming at the technical problems of the existing medicines for treating heart diseases, such as high drug dependence and addressing symptoms but not rooting causes. The traditional Chinese medicine composition for treating heart diseases comprises the following raw materials in parts by mass: 8-15 parts of ginseng, 5-15 parts of rhizoma ligustici wallichii, 10-18 parts of allium macrostemon, 6-15 parts of shizandra berry, 10-15 parts of lepidium seed, 15-25 parts of radix salviae miltiorrhizae, 10-17 parts of red peony root and 2-20 parts of the fruit of Chinese wolfberry. The traditional Chinese medicine composition for treating heart diseases disclosed by the invention can effectively improve myocardial functions, promote the recovery of injuries of myocardial tissues, and has good treatment effect; and clinical practice shows that the total effective rate of treating heart diseases reaches 90 percent above and the traditional Chinese medicine composition has no side or toxic effects.
Description
Technical field
The present invention relates to treatment cardiotropic formulation technical field, specifically one treats cardiopathic Chinese medicine composition.
Background technology
At society, heart disease has become the number one killer of mid-aged population, and their health in serious threat.The cause of heart disease is complicated, and disease indicia is varied, and as rheumatic heart disease, congenital heart disease, hypertensive heart disease, coronary heart disease, myocarditis etc., heart disease has become one of disease that in the many diseases of China, fatality rate is the highest.
The cardiopathic method of present western medical treatment is mainly at expansion and dredging vascellum, and to reach the object making unobstructed blood vessel, but Western medicine impels the health regulatory mechanism of patient to destroy, and easily causes human body to the dependence of medicine.Chinese patent medicine or natural extract are with its better tolerance, the features such as side effect is little comparatively have obvious advantage at control cardiac disease, now more by the clinical herbal species extensively quoted, but main with blood fat reducing, cholesterol reducing function is main, there is the course for the treatment of long, cure slow, cure the symptoms, not the disease, the problems such as medical expense is high, bring certain limitation to cardiopathic treatment.
Summary of the invention
The object of the invention is in order to solve the cardiopathic drug dependence effect of existing treatment large, cure the symptoms, not the disease, problem that the course for the treatment of is long, and the one provided treats cardiopathic Chinese medicine composition.
The technical solution used in the present invention is: one treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 8 ~ 15 parts, Rhizoma Chuanxiong 5 ~ 15 parts, Bulbus Allii Macrostemonis 10 ~ 18 parts, Fructus Schisandrae Chinensis 6 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 10 ~ 15 parts, Radix Salviae Miltiorrhizae 15 ~ 25 parts, Radix Paeoniae Rubra 10 ~ 17 parts, Fructus Lycii 2 ~ 20 parts.
Further, one treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 9 ~ 13 parts, Rhizoma Chuanxiong 9 ~ 11 parts, Bulbus Allii Macrostemonis 13 ~ 16 parts, Fructus Schisandrae Chinensis 8 ~ 12 parts, Semen Lepidii (Semen Descurainiae) 8 ~ 12 parts, Radix Salviae Miltiorrhizae 18 ~ 22 parts, Radix Paeoniae Rubra 13 ~ 16 parts, Fructus Lycii 5-15 part.
Further, one treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 11 parts, Rhizoma Chuanxiong 10 parts, Bulbus Allii Macrostemonis 15 parts, Fructus Schisandrae Chinensis 10 parts, Semen Lepidii (Semen Descurainiae) 9 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Paeoniae Rubra 14 parts, Fructus Lycii 13 parts.
Decoct and instructions of taking: getting above-mentioned Chinese medicine powder, to be broken into Chinese medicine coarse powder for subsequent use, in the Chinese medicine coarse powder of gained, add 5 times amount soak by water 2 times, 30 minutes first times, second time 20 minutes, collecting decoction, filter, both.Adult every day 1 time, a 200ml 4 weeks is a course for the treatment of.
A kind of medical material effect for the treatment of in cardiopathic Chinese medicine composition of the present invention is resolved as follows:
Sweet, the micro-hardship of Radix Ginseng nature and flavor, slightly warm in nature.Function is strongly invigorating primordial QI, and multiple arteries and veins takes off admittedly, and invigorating the spleen to benefit the lung, promotes the production of body fluid and nourish blood, Fructus Alpiniae Oxyphyllae of calming the nerves; Be rich in Ginsenosides, ginseng polysaccharide, volatile oil, sterols and aminoacid, vitamin etc., wherein Ginsenosides is main active.Large quantity research shows, ginsenoside can protecting myocardial cell, reduces blood pressure and blood lipoid level, resists myocardial ischemia.
Rhizoma Chuanxiong acrid in the mouth, slightly warm in nature.Function is blood circulation promoting and blood stasis dispelling, type gas dissipating depression of QI, wind-expelling pain-stopping, is used for the treatment of headache, and Rhizoma Chuanxiong Aqueous extracts and alkaloid thereof can expand crown and blood vessel, increases coronary flow, improves myocardial ischemia situation.Modern pharmacological research shows, ligustrazine has spasmolysis to vascular smooth muscle; Mitigation is had to the vasospasm caused by adrenal gland or potassium chloride; Can obviously reduce anesthetized dog coronary resistance and pulmonary hypertension.
Bulbus Allii Macrostemonis nature and flavor are pungent, bitter, temperature.Function is activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving.The compositions such as furostanol, volatile oil, nitrogen-containing compound, aminoacid are had from the compound be wherein separated.Macrostemonoside A can increase the activity of lipase in visceral adipocytes and obesity, and the structure of its steroid has the effect of potential protection cardiovascular system.
Fructus Schisandrae Chinensis sweet in the mouth, acid, warm in nature.Function is astringent or styptic treatment for spontaneous sweating for restraining, supplementing QI for promoting the production of body fluid, kidney calming.Fructus Schisandrae Chinensis has cardiotonic, and its infusion and rare alcohol immersion, can strengthen myocardial contraction, increases antiotasis.
Semen Lepidii (Semen Descurainiae) acrid in the mouth, hardship, cold in nature.Function eliminating the pathogens from the lung sending down the abnormal ascending QI, eliminating phlegm and relieving asthma.Modern pharmacological research shows, Semen Lepidii (Semen Descurainiae) ethanol extract can strengthen myocardial contraction, decreased heart rate, reduces conduction velocity.
Radix Salviae Miltiorrhizae bitter in the mouth, cold nature.Function is invigorated blood circulation dysmenorrhea, evacuation of pus granulation promoting, anti-inflammatory analgetic, menstruction regulating and pain relieving, and coronary artery dilator, improves myocardial ischemia situation, reduce blood pressure, and calms the nerves with all worries set aside, blood sugar lowering and antibacterial.Modern pharmacological research shows, Radix Salviae Miltiorrhizae has anti-platelet aggregation, reduces the function of blood viscosity and the inside and outside blood coagulation system of adjustment.
Radix Paeoniae Rubra nature and flavor are bitter, are slightly cold.Function is clearing away heat and cooling blood, eliminating stasis to stop pain.From Radix Paeoniae Rubra in isolated chemical composition, with monoterpene and monoterpene glycosides content more, be secondly triterpene and glycoside thereof, flavonoid, tannin class, sterols, organic acid and several amino acids and trace element.Modern pharmacological research shows, peoniflorin is by alleviating inflammatory cell infiltration and the penetrating protection acute lung injury of blood capillary, the myocardial ischemia reperfusion injury of cardioprotection.
Fructus Lycii sweet in the mouth, warm in nature.Function tonification bone marrow, nourishing the liver to improve visual acuity, YIN nourishing and the production of body fluid promoting.Fructus Lycii can protect the liver, blood sugar lowering, vessel softening, cholesterol, triglyceride levels in reduction blood, carotene contained in Fructus Lycii and multivitamin can effective prevention of cardiac.
In side, Radix Ginseng, Rhizoma Chuanxiong, Bulbus Allii Macrostemonis, Fructus Schisandrae Chinensis, Semen Lepidii (Semen Descurainiae) energy coronary artery dilator, increase coronary artery blood flow, improve myocardial oxygen consumption situation, alleviate or eliminate arrhythmia; Radix Salviae Miltiorrhizae supplementing QI and nourishing YIN, is equipped with Radix Paeoniae Rubra promoting flow of QI and blood, makes perfect square tonify without causing stagnation; The product easily impairment of YIN of a specified duration of warm-dryness syndrome, Fructus Lycii moisturizes YIN nourishing, alleviates warm-dryness syndrome.
The present invention has following beneficial effect:
One, medicine of the present invention, with Radix Ginseng, Rhizoma Chuanxiong, Bulbus Allii Macrostemonis, Fructus Schisandrae Chinensis, Semen Lepidii (Semen Descurainiae) energy coronary artery dilator, increases coronary artery blood flow, improves myocardial oxygen consumption situation, alleviate or eliminate arrhythmia; Radix Salviae Miltiorrhizae supplementing QI and nourishing YIN, is equipped with Radix Paeoniae Rubra promoting flow of QI and blood, makes perfect square tonify without causing stagnation; The product easily impairment of YIN of a specified duration of warm-dryness syndrome, Fructus Lycii moisturizes YIN nourishing, alleviates warm-dryness syndrome.
Two, medicine of the present invention, focuses on the relation of the integrally-regulated and heart of human body, improves the adaptation state of destructive stimulus, to nurse one's health heart body for therapeutic purposes, takes stopgap measures and effects a permanent cure with executing; And formula Chinese crude drug is easy to get, each medical material all has no side effect, and long-term taking also can not damage internal organs, and drug dependence is less, and medication is safer.
Three, medicine of the present invention, to heart disease determined curative effect, effectively can reduce the harm that heart disease brings, effective percentage, more than 90%, is worth at clinical expansion.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further elaborated.
Embodiment 1:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 8 parts, Rhizoma Chuanxiong 5 parts, Bulbus Allii Macrostemonis 10 parts, Fructus Schisandrae Chinensis 6 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, Fructus Lycii 2 parts.
Decoct and instructions of taking: getting above-mentioned Chinese medicine powder, to be broken into Chinese medicine coarse powder for subsequent use, in the Chinese medicine coarse powder of gained, add 5 times amount soak by water 2 times, 30 minutes first times, second time 20 minutes, collecting decoction, filter, both.Adult every day 1 time, a 200ml 4 weeks is a course for the treatment of.
Embodiment 2:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 15 parts, Rhizoma Chuanxiong 15 parts, Bulbus Allii Macrostemonis 18 parts, Fructus Schisandrae Chinensis 15 parts, Semen Lepidii (Semen Descurainiae) 15 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Paeoniae Rubra 17 parts, Fructus Lycii 20 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 3:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 11 parts, Rhizoma Chuanxiong 10 parts, Bulbus Allii Macrostemonis 15 parts, Fructus Schisandrae Chinensis 10 parts, Semen Lepidii (Semen Descurainiae) 9 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Paeoniae Rubra 14 parts, Fructus Lycii 13 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 4:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 9 parts, Rhizoma Chuanxiong 9 parts, Bulbus Allii Macrostemonis 13 parts, Fructus Schisandrae Chinensis 8 parts, Semen Lepidii (Semen Descurainiae) 8 parts, Radix Salviae Miltiorrhizae 18 parts, Radix Paeoniae Rubra 13 parts, Fructus Lycii 5 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 5:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 13 parts, Rhizoma Chuanxiong 11 parts, Bulbus Allii Macrostemonis 16 parts, Fructus Schisandrae Chinensis 12 parts, Semen Lepidii (Semen Descurainiae) 12 parts, Radix Salviae Miltiorrhizae 22 parts, Radix Paeoniae Rubra 16 parts, Fructus Lycii 15 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 6:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 8 parts, Rhizoma Chuanxiong 5 parts, Bulbus Allii Macrostemonis 18 parts, Fructus Schisandrae Chinensis 15 parts, Semen Lepidii (Semen Descurainiae) 15 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Paeoniae Rubra 17 parts, Fructus Lycii 20 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 7:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 15 parts, Rhizoma Chuanxiong 15 parts, Bulbus Allii Macrostemonis 10 parts, Fructus Schisandrae Chinensis 6 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, Fructus Lycii 2 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Embodiment 8:
One treats cardiopathic Chinese medicine composition, is made up of the raw material of following mass fraction: Radix Ginseng 8 parts, Rhizoma Chuanxiong 15 parts, Bulbus Allii Macrostemonis 18 parts, Fructus Schisandrae Chinensis 15 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Paeoniae Rubra 17 parts, Fructus Lycii 20 parts.
The process for preparing medicine step of the present embodiment and usage and dosage identical with embodiment 1.
Clinical data and case:
In order to show therapeutic effect of the present invention, system clinical observation treatment being carried out to 98 routine cardiacs, in the process of above-mentioned clinical observation, record being carried out to the medical history of above-mentioned patient, the state of an illness and curative effect.
Clinical therapeutic efficacy criterion is:
Cure: common sign as cardiopalmus, breathe hard, uncomfortable in chest, pale complexion, extremity are numb, tongue fur presents cracking many, angina pectoris all disappears.
Take a turn for the better: subjective symptoms as cardiopalmus, breathe hard, uncomfortable in chest, extremity are numb, tongue fur presents cracking many, angina pectoris disappears substantially, complexion is tending towards normal.
Invalid: symptom, sign are not improved.
Therapeutic effect: a kind of Chinese prescription for the treatment of insufficiency of heart-QI of the present invention is treated through 98 routine cardiac conditions patients, 79 example recoveries from illness, 10 examples take a turn for the better, and 9 examples are invalid, and total effective rate reaches 90.8%.
Model case:
Case 1: patient Jiang, man, 48 years old, suffered from a heart complaint disease 11 years, long-term cardiopalmus, breathe hard, uncomfortable in chest, pale complexion, extremity are numb, through observe tongue fur present cracking many, Measure blood pressure, high pressure 170 to 180, low pressure 110 to 120, the electrocardiographic diagnosis through doctor trained in Western medicine is that hypertensive cerebral distension related to the heart is sick.Take Chinese medicine of the present invention after 5 months, symptom disappears completely, and blood pressure is normal, follows up a case by regular visits to and does not recur for 1 year.
Case 2: patient Lee, female, 40 years old, suffered from a heart complaint disease 3 years, and long-term discomfort uncomfortable in chest, angina pectoris, insomnia, neck stiffness, tachycardia lip are dry purple, be coronary heart disease after diagnosing, coronary insufficiency, in cardiopulmonary greatly.Take Chinese medicine of the present invention after 6 months, symptom disappears completely, and pulse condition is normal, follows up a case by regular visits to and does not recur for 1 year.
Case 3: grandson patient so-and-so, man, 38 years old, suffered from a heart complaint card, conscious severe palpitation, and take Chinese medicine of the present invention after 2 months, symptom disappears completely, and pulse condition normally, is followed up a case by regular visits to and do not recurred for 1 year.
Claims (3)
1. the cardiopathic Chinese medicine composition for the treatment of, it is characterized in that, be made up of the raw material of following mass fraction: Radix Ginseng 8 ~ 15 parts, Rhizoma Chuanxiong 5 ~ 15 parts, Bulbus Allii Macrostemonis 10 ~ 18 parts, Fructus Schisandrae Chinensis 6 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 10 ~ 15 parts, Radix Salviae Miltiorrhizae 15 ~ 25 parts, Radix Paeoniae Rubra 10 ~ 17 parts, Fructus Lycii 2 ~ 20 parts.
2. one according to claim 1 treats cardiopathic Chinese medicine composition, it is characterized in that, be made up of the raw material of following mass fraction: Radix Ginseng 9 ~ 13 parts, Rhizoma Chuanxiong 9 ~ 11 parts, Bulbus Allii Macrostemonis 13 ~ 16 parts, Fructus Schisandrae Chinensis 8 ~ 12 parts, Semen Lepidii (Semen Descurainiae) 8 ~ 12 parts, Radix Salviae Miltiorrhizae 18 ~ 22 parts, Radix Paeoniae Rubra 13 ~ 16 parts, Fructus Lycii 5-15 part.
3. one according to claim 1 treats cardiopathic Chinese medicine composition, it is characterized in that, is made up of the raw material of following mass fraction: Radix Ginseng 11 parts, Rhizoma Chuanxiong 10 parts, Bulbus Allii Macrostemonis 15 parts, Fructus Schisandrae Chinensis 10 parts, Semen Lepidii (Semen Descurainiae) 9 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Paeoniae Rubra 14 parts, Fructus Lycii 13 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717143.4A CN104324205A (en) | 2014-11-29 | 2014-11-29 | Traditional Chinese medicine composition for treating heart diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410717143.4A CN104324205A (en) | 2014-11-29 | 2014-11-29 | Traditional Chinese medicine composition for treating heart diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104324205A true CN104324205A (en) | 2015-02-04 |
Family
ID=52399095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410717143.4A Pending CN104324205A (en) | 2014-11-29 | 2014-11-29 | Traditional Chinese medicine composition for treating heart diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104324205A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111249385A (en) * | 2020-04-07 | 2020-06-09 | 江苏康缘药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for treating coronary heart disease |
| CN115998815A (en) * | 2023-01-29 | 2023-04-25 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for delaying atherosclerosis and renal insufficiency progression and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349803A (en) * | 2000-10-20 | 2002-05-22 | 孙喆 | Medicine for treating diabetes and coronary heart disease |
| CN1958034A (en) * | 2006-12-04 | 2007-05-09 | 杨梅青 | Medication for treating cardiovascular disease |
| US20090208596A1 (en) * | 2006-09-13 | 2009-08-20 | Brion Research Institute Of Taiwan | Medical Herb Composition for the Alleviation of Cardiopulmonary Ailments or the Improvement of Cardiopulmonary Function in a Mammal |
-
2014
- 2014-11-29 CN CN201410717143.4A patent/CN104324205A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1349803A (en) * | 2000-10-20 | 2002-05-22 | 孙喆 | Medicine for treating diabetes and coronary heart disease |
| US20090208596A1 (en) * | 2006-09-13 | 2009-08-20 | Brion Research Institute Of Taiwan | Medical Herb Composition for the Alleviation of Cardiopulmonary Ailments or the Improvement of Cardiopulmonary Function in a Mammal |
| CN1958034A (en) * | 2006-12-04 | 2007-05-09 | 杨梅青 | Medication for treating cardiovascular disease |
Non-Patent Citations (2)
| Title |
|---|
| 杨建宇等: "中医药治疗心系疾病汇讲", 《中国中医药现代远程教育》 * |
| 韩雪杰等: "《冠心病临床药对新用》", 31 October 2005, 中国医药科技出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111249385A (en) * | 2020-04-07 | 2020-06-09 | 江苏康缘药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for treating coronary heart disease |
| CN115998815A (en) * | 2023-01-29 | 2023-04-25 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for delaying atherosclerosis and renal insufficiency progression and application thereof |
| CN115998815B (en) * | 2023-01-29 | 2024-01-30 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating acute coronary syndrome complicated with renal insufficiency and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463409B (en) | Traditional Chinese medicine formula for treating heart qi deficiency | |
| CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
| CN104083438A (en) | Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN104324205A (en) | Traditional Chinese medicine composition for treating heart diseases | |
| CN102600351B (en) | Traditional Chinese medicine for treating pruritus cutanea | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN104288255A (en) | Traditional Chinese medicine preparation for treating severe acute pancreatitis | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103127255B (en) | Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof | |
| CN105169149A (en) | Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application | |
| CN104524288A (en) | Traditional Chinese medicinal composition for treating hypertension | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103405660A (en) | Compound medicine for treating headache | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102028876B (en) | Liquid Chinese medicine for treating hyperosteogeny | |
| CN102008665A (en) | Chinese medicament for treating night sweat | |
| CN104840551A (en) | Hypertension relieving mulberry leaf Chinese medicine preparation and preparing method | |
| CN104906375B (en) | A kind of Chinese medicine composition for treating Qi dysfunction in blood control type purpura | |
| CN105169324A (en) | Chinese herba preparation for prevention and treatment of common cold due to wind-cold | |
| CN104352773A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma | |
| CN105396082A (en) | Insomnia and dreaminess treating traditional Chinese medicine composition | |
| CN104587397A (en) | Traditional Chinese medicinal composition for treating endocrine dyscrasia | |
| CN103202991A (en) | Drug for treatment of coronary heart disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150204 |